Allspring SMID Cap Growth Fund reports on Q4 market rotations and performance drivers like Teva and Natera. Read the full ...

Allspring SMID Cap Growth Fund reviews Q4 2025 performance and identifies high-quality growth opportunities. Read the full ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, ...

Teva Pharmaceutical Industries (NYSE: TEVA) is an interesting investment story. For the right investor, it could be an attractive buy. For me, however, it isn't. Here's the opportunity that Teva has ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy healthcare stocks to invest in. Teva ...

Teva Pharmaceutical Industries (NYSE:TEVA) and Sanofi reported positive 44 week data from the RELIEVE UCCD study for duvakitug in ulcerative colitis and Crohn's disease. The investigational monoclonal ...

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.

Brisk recent share momentum has re-focused attention on Teva’s earnings profile and balance-sheet positioning Intrinsic-value narratives often lean on modest revenue progress paired with stronger ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate ...

SIPTU has said it is engaging with management at Teva Pharmaceuticals over threatened redundancies at its plant in Waterford.

On February 23, Steven Wieting, CIO Group chief investment strategist, appeared on CNBC’s ‘The Exchange’ to talk about the ...

Israel-based generics giant Teva Industries and France’s Medincell announced that the US Food and Drug Administration has accepted the New Drug Application for olanzapine extended-release injectable ...